Old Web
English
Sign In
Acemap
>
authorDetail
>
James Atherton
James Atherton
Pfizer
Chemistry
Biochemistry
IC50
Stereochemistry
Chromatography
5
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCθ inhibitors
2010
Bioorganic & Medicinal Chemistry Letters
Diane Harris Boschelli
Joan Subrath
Chuansheng Niu
Biqi Wu
Yan Wang
Julie Lee
Agnes Brennan
Melisa Ho
Bijia Deng
Xiaoke Yang
Xin Xu
Louis Leung
Jianyao Wang
James Atherton
Divya Chaudhary
Show All
Source
Cite
Save
Citations (15)
P2Y1 receptor antagonists as novel antithrombotic agents.
2008
Bioorganic & Medicinal Chemistry Letters
Jeffrey A. Pfefferkorn
Chulho Choi
Thomas Winters
Robert Michael Kennedy
Liguo Chi
Lisa A. Perrin
Gina H. Lu
Yun-Wen Ping
Tom McClanahan
Richard Schroeder
Michael T. Leininger
Andrew George Geyer
Sabine Schefzick
James Atherton
Show All
Source
Cite
Save
Citations (41)
Sample pooling to enhance throughput of brain penetration study
1999
Journal of Pharmaceutical and Biomedical Analysis
James Atherton
Ted Van Noord
Be-Sheng Kuo
Show All
Source
Cite
Save
Citations (12)
Syntheses and biological activities of chiral piperidines-tachykinin NK3 antagonists
1999
Acta Pharmacologica Sinica
Michael H Chen
Fu-Zon Chung
Bruce David Roth
Be-Sheng Kuo
James Atherton
Helen Tsenwhei Lee
Show All
Source
Cite
Save
Citations (3)
Development and application of sensitive HPLC assays for NK 3 antagonists in rat plasma 1 Presented at the Eighth International Symposium on Pharmaceutical and Biomedical Analysis (PBA '97), Orlando, FL, USA, 4–8 May, 1997. 1
1998
Journal of Pharmaceutical and Biomedical Analysis
James Atherton
Be-Sheng Kuo
Show All
Source
Cite
Save
Citations (0)
1